Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

计划入组 37 人 · 首次发布于 2020 年 7 月 24 日

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

计划入组 12 人 · 首次发布于 2023 年 7 月 3 日

REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

计划入组 108 人 · 首次发布于 2020 年 2 月 19 日

allogeneic human blood serum therapy (Neurotrophic Keratitis)

mesenchymal stem cell-derived exosomes (neurotrophic keratitis)

Cenegermin(Oxervate)

Rx

Oculis

Switzerland

Regeneron Pharmaceuticals

United States

Neurotronic, Inc.

United States

EyeDura Partners with Singapore Eye Research Institute for Insulin-Based Neurotrophic Keratitis Treatment

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep in Neurotrophic Keratitis, Initiates Phase 2 Trial

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Gene Therapy Vector